Track the latest Cytokinetics insider trading activity. Stay informed on recent buys, sells, and market impact for Cytokinetics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Cytokinetics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 15.43K shares worth $1.17M, meanwhile, insiders have report no purchases in the last 30 days.
Browse insider trades on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
| Jun 09, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $37.89 | -$210.63K | SELL-OPTIONS | 0.00% | 153.90K | Jun 09 | View |
| Jun 01, 2026 | Dr. Kaye | DIRECTOR | -2.93K | $76.09 | -$223.17K | SELL | -22.19% | 10.28K | Jun 01 | View |
| Jun 01, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $48.67 | -$762.30K | SELL-OPTIONS | 0.00% | 58.55K | Jun 01 | View |
| Jun 01, 2026 | LYNNE PARSHALL | DIRECTOR | -5.00K | $74.08 | -$370.40K | SELL | -24.06% | 15.78K | Jun 01 | View |
| May 28, 2026 | Robert Blum | PRESIDENT & CEO | -7.50K | $77.21 | -$579.08K | SELL | -1.86% | 394.91K | May 27 | View |
| May 20, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $41.74 | -$237.62K | SELL-OPTIONS | 0.00% | 153.90K | May 19 | View |
| May 14, 2026 | Robert Blum | PRESIDENT & CEO | -7.50K | $77.92 | -$584.40K | SELL | -1.83% | 402.41K | May 14 | View |
| May 05, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $42.59 | -$243.50K | SELL-OPTIONS | 0.00% | 153.90K | May 05 | View |
| May 05, 2026 | Dr. Wierenga | DIRECTOR | 0.00 | $43.70 | -$252.40K | SELL-OPTIONS | 0.00% | 32.64K | May 05 | View |
| May 05, 2026 | Sung Lee | EVP, CHIEF FINANCIAL OFFICER | -23.91K | $76.87 | -$1.84M | SELL | -27.44% | 63.22K | May 05 | View |
| May 05, 2026 | Dr. Henderson | DIRECTOR | 0.00 | $41.79 | -$1.37M | SELL-OPTIONS | 0.00% | 75.32K | May 05 | View |
| May 05, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $58.19 | -$432.01K | SELL-OPTIONS | 0.00% | 58.55K | May 05 | View |
| May 04, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $51.31 | -$434.01K | SELL-OPTIONS | 0.00% | 58.55K | May 01 | View |
| Apr 30, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $43.26 | -$600.00K | SELL-OPTIONS | 0.00% | 58.55K | Apr 30 | View |
| Apr 29, 2026 | Robert Blum | PRESIDENT & CEO | -7.50K | $59.62 | -$447.15K | SELL | -1.80% | 409.91K | Apr 29 | View |
| Apr 21, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $36.74 | -$202.62K | SELL-OPTIONS | 0.00% | 153.90K | Apr 21 | View |
| Apr 15, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -7.45K | $66.02 | -$491.78K | SELL | -11.29% | 58.55K | Apr 15 | View |
| Apr 15, 2026 | Robert Blum | PRESIDENT & CEO | -7.50K | $65.38 | -$490.35K | SELL | -1.77% | 417.41K | Apr 15 | View |
| Apr 08, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $36.77 | -$255.09K | SELL-OPTIONS | 0.00% | 153.90K | Apr 07 | View |
| Apr 01, 2026 | Robert Blum | PRESIDENT & CEO | -7.50K | $66.63 | -$499.72K | SELL | -1.73% | 424.91K | Apr 01 | View |
| Mar 31, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -3.64K | $65.00 | -$236.53K | SELL | -5.23% | 66.00K | Mar 31 | View |
| Mar 18, 2026 | Sung Lee | EVP, CHIEF FINANCIAL OFFICER | -4.93K | $62.15 | -$306.71K | SELL | -5.36% | 87.13K | Mar 17 | View |
| Mar 18, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -8.54K | $62.15 | -$530.89K | SELL | -10.66% | 71.57K | Mar 17 | View |
| Mar 18, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -12.03K | $62.15 | -$747.85K | SELL | -7.25% | 153.90K | Mar 17 | View |
| Mar 18, 2026 | Robert Blum | PRESIDENT & CEO | -36.60K | $62.15 | -$2.27M | SELL | -7.80% | 432.41K | Mar 17 | View |
| Mar 18, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -1.93K | $62.07 | -$119.80K | SELL | -2.41% | 78.19K | Mar 18 | View |
| Mar 16, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -1.71K | $61.03 | -$104.30K | SELL | -3.57% | 46.15K | Mar 16 | View |
| Mar 10, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -2.58K | $60.72 | -$156.78K | SELL | -5.12% | 47.86K | Mar 09 | View |
| Mar 10, 2026 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.91K | $60.72 | -$176.51K | SELL | -2.05% | 138.63K | Mar 09 | View |
| Mar 10, 2026 | Robert Blum | PRESIDENT & CEO | -7.93K | $60.72 | -$481.57K | SELL | -1.97% | 393.76K | Mar 09 | View |
| Mar 05, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $45.92 | -$829.40K | SELL-OPTIONS | 0.00% | 65.44K | Mar 05 | View |
| Mar 02, 2026 | LYNNE PARSHALL | DIRECTOR | -5.00K | $61.21 | -$306.05K | SELL | -21.80% | 17.93K | Mar 02 | View |
| Mar 02, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $49.63 | -$21.26K | SELL-OPTIONS | 0.00% | 50.44K | Mar 02 | View |
| Feb 05, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $42.59 | -$580.05K | SELL-OPTIONS | 0.00% | 50.44K | Feb 05 | View |
| Feb 02, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $49.87 | -$21.68K | SELL-OPTIONS | 0.00% | 50.44K | Feb 02 | View |
| Jan 05, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $41.77 | -$555.30K | SELL-OPTIONS | 0.00% | 50.44K | Jan 05 | View |
| Jan 02, 2026 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -913.00 | $50.12 | -$79.28K | SELL | -1.78% | 50.44K | Jan 02 | View |
| Dec 30, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -1.81K | $62.44 | -$112.95K | SELL | -3.40% | 51.35K | Dec 29 | View |
| Dec 23, 2025 | Dr. Wierenga | DIRECTOR | 0.00 | $36.88 | -$1.17M | SELL-OPTIONS | 0.00% | 32.44K | Dec 22 | View |
| Dec 16, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $35.92 | -$111.41K | SELL-OPTIONS | 0.00% | 138.55K | Dec 16 | View |
| Dec 08, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $52.55 | -$27.96K | SELL-OPTIONS | 0.00% | 50.66K | Dec 08 | View |
| Dec 05, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $49.89 | -$1.69M | SELL-OPTIONS | 0.00% | 50.66K | Dec 05 | View |
| Dec 02, 2025 | Dr. Henderson | DIRECTOR | 0.00 | $36.95 | -$471.63K | SELL-OPTIONS | 0.00% | 74.66K | Dec 02 | View |
| Dec 02, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $37.24 | -$117.24K | SELL-OPTIONS | 0.00% | 140.61K | Dec 02 | View |
| Dec 02, 2025 | Dr. Kaye | DIRECTOR | 0.00 | $40.22 | -$1.49M | SELL-OPTIONS | 0.00% | 9.98K | Dec 01 | View |
| Dec 02, 2025 | Dr. Harrington | DIRECTOR | -2.15K | $66.80 | -$143.62K | SELL | -10.39% | 18.54K | Dec 01 | View |
| Nov 19, 2025 | LYNNE PARSHALL | DIRECTOR | -5.00K | $64.73 | -$323.65K | SELL | -17.90% | 22.93K | Nov 19 | View |
| Nov 18, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $38.52 | -$122.87K | SELL-OPTIONS | 0.00% | 140.61K | Nov 18 | View |
| Nov 12, 2025 | Dr. Kaye | DIRECTOR | 0.00 | $37.37 | -$286.80K | SELL-OPTIONS | 0.00% | 9.98K | Nov 11 | View |
| Nov 04, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $35.07 | -$112.34K | SELL-OPTIONS | 0.00% | 140.61K | Nov 04 | View |
| Oct 30, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $62.86 | -$314.30K | SELL | -1.37% | 360.19K | Oct 30 | View |
| Oct 27, 2025 | Dr. Wierenga | DIRECTOR | 0.00 | $34.34 | -$212.97K | SELL-OPTIONS | 0.00% | 32.44K | Oct 27 | View |
| Oct 21, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $34.41 | -$100.24K | SELL-OPTIONS | 0.00% | 140.61K | Oct 21 | View |
| Oct 16, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $60.03 | -$300.15K | SELL | -1.35% | 365.19K | Oct 16 | View |
| Oct 07, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $35.58 | -$99.92K | SELL-OPTIONS | 0.00% | 140.61K | Oct 07 | View |
| Oct 06, 2025 | Dr. Kaye | DIRECTOR | -6.76K | $60.00 | -$405.42K | SELL | -40.86% | 9.78K | Oct 06 | View |
| Oct 01, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $55.05 | -$275.25K | SELL | -1.33% | 370.19K | Oct 01 | View |
| Sep 30, 2025 | Dr. Kaye | DIRECTOR | -6.70K | $55.08 | -$368.76K | SELL | -28.82% | 16.54K | Sep 30 | View |
| Sep 23, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $29.94 | -$77.36K | SELL-OPTIONS | 0.00% | 140.61K | Sep 23 | View |
| Sep 15, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $49.77 | -$248.85K | SELL | -1.32% | 375.19K | Sep 15 | View |
| Sep 10, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $30.95 | -$81.38K | SELL-OPTIONS | 0.00% | 140.61K | Sep 09 | View |
| Sep 02, 2025 | Dr. Kaye | DIRECTOR | -6.76K | $50.00 | -$337.80K | SELL | -22.53% | 23.23K | Sep 02 | View |
| Sep 02, 2025 | Dr. Harrington | DIRECTOR | -2.15K | $48.67 | -$104.64K | SELL | -9.50% | 20.49K | Sep 02 | View |
| Sep 02, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $48.76 | -$243.80K | SELL | -1.30% | 380.19K | Sep 02 | View |
| Aug 19, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $24.46 | -$55.42K | SELL-OPTIONS | 0.00% | 140.61K | Aug 19 | View |
| Aug 15, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $38.42 | -$192.10K | SELL | -1.28% | 385.19K | Aug 15 | View |
| Aug 05, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $23.47 | -$51.48K | SELL-OPTIONS | 0.00% | 140.61K | Aug 05 | View |
| Jul 31, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $36.45 | -$182.25K | SELL | -1.27% | 390.19K | Jul 29 | View |
| Jul 23, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $24.04 | -$53.74K | SELL-OPTIONS | 0.00% | 140.61K | Jul 22 | View |
| Jul 15, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $38.15 | -$190.75K | SELL | -1.25% | 395.19K | Jul 14 | View |
| Jul 08, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $22.18 | -$46.32K | SELL-OPTIONS | 0.00% | 140.61K | Jul 08 | View |
| Jul 02, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $33.55 | -$167.75K | SELL | -1.23% | 400.19K | Jul 01 | View |
| Jun 17, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $21.75 | -$44.62K | SELL-OPTIONS | 0.00% | 140.61K | Jun 17 | View |
| Jun 16, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $33.80 | -$169.00K | SELL | -1.22% | 405.19K | Jun 16 | View |
| Jun 05, 2025 | Dr. Kaye | DIRECTOR | -3.64K | $32.10 | -$116.72K | SELL | -10.92% | 29.66K | Jun 05 | View |
| Jun 05, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -8.66K | $32.04 | -$277.43K | SELL | -14.27% | 52.03K | Jun 05 | View |
| Jun 03, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $21.24 | -$42.56K | SELL-OPTIONS | 0.00% | 140.61K | Jun 03 | View |
| Jun 02, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $31.22 | -$156.10K | SELL | -1.20% | 410.19K | Jun 02 | View |
| May 20, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $21.29 | -$42.76K | SELL-OPTIONS | 0.00% | 140.25K | May 20 | View |
| May 16, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $30.93 | -$154.65K | SELL | -1.19% | 414.71K | May 16 | View |
| May 15, 2025 | Muna Bhanji | DIRECTOR | -1.45K | $29.73 | -$43.23K | SELL | -5.82% | 23.51K | May 15 | View |
| May 06, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $22.80 | -$48.82K | SELL-OPTIONS | 0.00% | 140.25K | May 06 | View |
| May 05, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -4.00K | $36.68 | -$146.79K | SELL | -6.19% | 60.69K | May 05 | View |
| Apr 29, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $40.96 | -$204.80K | SELL | -1.18% | 419.71K | Apr 29 | View |
| Apr 22, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $24.36 | -$55.02K | SELL-OPTIONS | 0.00% | 140.25K | Apr 22 | View |
| Apr 21, 2025 | Dr. Wierenga | DIRECTOR | 0.00 | $22.34 | -$645.00K | SELL-OPTIONS | 0.00% | 24.85K | Apr 21 | View |
| Apr 16, 2025 | Dr. Henderson | DIRECTOR | 16.81K | $22.43 | $874.60 | SELL-OPTIONS | 33.88% | 66.43K | Apr 15 | View |
| Apr 10, 2025 | Robert Blum | PRESIDENT & CEO | -5.00K | $36.77 | -$183.85K | SELL | -1.16% | 424.71K | Apr 10 | View |
| Apr 08, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $23.39 | -$51.16K | SELL-OPTIONS | 0.00% | 140.25K | Apr 08 | View |
| Apr 07, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -2.89K | $35.78 | -$103.26K | SELL | -4.27% | 64.69K | Apr 07 | View |
| Apr 04, 2025 | Dr. Harrington | DIRECTOR | -450.00 | $39.43 | -$17.74K | SELL | -2.98% | 14.66K | Apr 03 | View |
| Mar 31, 2025 | Robert Blum | PRESIDENT & CEO | -15.00K | $40.75 | -$611.25K | SELL | -3.37% | 429.71K | Mar 31 | View |
| Mar 18, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $27.09 | -$65.96K | SELL-OPTIONS | 0.00% | 140.46K | Mar 18 | View |
| Mar 17, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -2.77K | $44.38 | -$123.15K | SELL | -7.37% | 34.89K | Mar 17 | View |
| Mar 17, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.39K | $44.38 | -$194.78K | SELL | -4.16% | 101.00K | Mar 17 | View |
| Mar 17, 2025 | Robert Blum | PRESIDENT & CEO | -12.65K | $44.38 | -$561.32K | SELL | -3.71% | 328.62K | Mar 17 | View |
| Mar 17, 2025 | Robert Blum | PRESIDENT & CEO | -25.00K | $44.65 | -$1.12M | SELL | -6.83% | 341.26K | Mar 17 | View |
| Mar 17, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $34.20 | -$457.29K | SELL-OPTIONS | 0.00% | 37.66K | Mar 17 | View |
| Mar 14, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $34.13 | -$2.17K | SELL-OPTIONS | 0.00% | 37.66K | Mar 14 | View |
| Mar 13, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -26.77K | $43.62 | -$1.17M | SELL | -41.55% | 37.66K | Mar 13 | View |
| Mar 07, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -3.34K | $43.27 | -$144.57K | SELL | -4.93% | 64.43K | Mar 06 | View |
| Mar 07, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -8.23K | $43.27 | -$356.03K | SELL | -7.24% | 105.39K | Mar 06 | View |
| Mar 07, 2025 | Robert Blum | PRESIDENT & CEO | -16.97K | $43.44 | -$737.18K | SELL | -4.43% | 366.26K | Mar 06 | View |
| Mar 05, 2025 | Robert Blum | PRESIDENT & CEO | -25.00K | $43.23 | -$1.08M | SELL | -6.12% | 383.23K | Mar 05 | View |
| Mar 05, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.45K | $42.88 | -$105.01K | SELL | -2.11% | 113.62K | Mar 03 | View |
| Mar 05, 2025 | Andrew Callos | EVP, CHIEF COMMERCIAL OFFICER | -1.11K | $42.88 | -$47.77K | SELL | -1.62% | 67.78K | Mar 03 | View |
| Mar 05, 2025 | Robert Blum | PRESIDENT & CEO | -8.74K | $42.88 | -$374.90K | SELL | -2.10% | 408.23K | Mar 03 | View |
| Mar 04, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $26.55 | -$63.80K | SELL-OPTIONS | 0.00% | 116.07K | Mar 04 | View |
| Mar 04, 2025 | Dr. Harrington | DIRECTOR | -900.00 | $42.50 | -$38.25K | SELL | -5.62% | 15.11K | Mar 04 | View |
| Feb 18, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $28.29 | -$70.76K | SELL-OPTIONS | 0.00% | 116.07K | Feb 18 | View |
| Feb 04, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $29.33 | -$74.92K | SELL-OPTIONS | 0.00% | 116.07K | Feb 04 | View |
| Jan 21, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $28.26 | -$70.64K | SELL-OPTIONS | 0.00% | 116.07K | Jan 21 | View |
| Jan 10, 2025 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $29.96 | -$77.44K | SELL-OPTIONS | 0.00% | 116.07K | Jan 07 | View |
| Dec 16, 2024 | Dr. Wierenga | DIRECTOR | 0.00 | $27.99 | -$30.60K | SELL-OPTIONS | 0.00% | 24.56K | Dec 16 | View |
| Dec 12, 2024 | Dr. Henderson | DIRECTOR | 10.09K | $28.90 | -$2.25K | SELL-OPTIONS | 26.18% | 48.64K | Dec 11 | View |
| Dec 10, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $29.30 | -$327.45K | SELL | -1.69% | 116.07K | Dec 10 | View |
| Dec 02, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $28.71 | -$220.45K | SELL-OPTIONS | 0.00% | 399.76K | Dec 02 | View |
| Nov 26, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $29.06 | -$323.99K | SELL | -1.76% | 111.88K | Nov 26 | View |
| Nov 26, 2024 | Dr. Wierenga | DIRECTOR | 0.00 | $28.68 | -$31.63K | SELL-OPTIONS | 0.00% | 24.56K | Nov 25 | View |
| Nov 19, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $28.61 | -$219.40K | SELL-OPTIONS | 0.00% | 399.54K | Nov 18 | View |
| Nov 13, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -1.04K | $33.22 | -$328.69K | SELL | -0.91% | 113.88K | Nov 12 | View |
| Nov 04, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $29.15 | -$224.80K | SELL-OPTIONS | 0.00% | 399.54K | Nov 01 | View |
| Oct 31, 2024 | Dr. Wierenga | DIRECTOR | 0.00 | $29.81 | -$199.81K | SELL-OPTIONS | 0.00% | 24.56K | Oct 28 | View |
| Oct 31, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $29.93 | -$336.74K | SELL | -1.71% | 114.92K | Oct 30 | View |
| Oct 16, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $31.07 | -$353.37K | SELL | -1.68% | 116.92K | Oct 15 | View |
| Oct 10, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $31.14 | -$244.70K | SELL-OPTIONS | 0.00% | 399.54K | Oct 09 | View |
| Oct 01, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $30.03 | -$338.11K | SELL | -1.65% | 118.92K | Oct 01 | View |
| Sep 30, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $29.41 | -$227.35K | SELL-OPTIONS | 0.00% | 399.54K | Sep 30 | View |
| Sep 17, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $32.36 | -$372.21K | SELL | -1.63% | 120.92K | Sep 17 | View |
| Sep 17, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $31.33 | -$246.60K | SELL-OPTIONS | 0.00% | 399.54K | Sep 16 | View |
| Sep 09, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $38.27 | -$166.55K | SELL-OPTIONS | 0.00% | 20.60K | Sep 09 | View |
| Sep 03, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.08K | $32.49 | -$378.79K | SELL | -1.67% | 122.92K | Sep 03 | View |
| Sep 03, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $31.85 | -$251.80K | SELL-OPTIONS | 0.00% | 399.54K | Sep 03 | View |
| Aug 26, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $39.44 | -$178.25K | SELL-OPTIONS | 0.00% | 20.60K | Aug 26 | View |
| Aug 22, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $32.11 | -$368.45K | SELL | -1.57% | 125.00K | Aug 20 | View |
| Aug 12, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $30.92 | -$557.75K | SELL-OPTIONS | 0.00% | 401.50K | Aug 12 | View |
| Aug 12, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $38.41 | -$167.95K | SELL-OPTIONS | 0.00% | 20.60K | Aug 12 | View |
| Aug 07, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $30.84 | -$349.90K | SELL | -1.59% | 123.70K | Aug 06 - Aug 07 | View |
| Jul 31, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $40.73 | -$191.15K | SELL-OPTIONS | 0.00% | 20.60K | Jul 29 | View |
| Jul 31, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $33.08 | -$607.43K | SELL-OPTIONS | 0.00% | 401.50K | Jul 30 | View |
| Jul 23, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $32.49 | -$374.06K | SELL | -1.53% | 129.00K | Jul 23 | View |
| Jul 16, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $33.25 | -$225.70K | SELL-OPTIONS | 0.00% | 20.60K | Jul 15 | View |
| Jul 10, 2024 | Robert Blum | PRESIDENT & CEO | -5.73K | $30.48 | -$585.87K | SELL | -1.41% | 401.50K | Jul 10 | View |
| Jul 09, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $31.93 | -$365.92K | SELL | -1.50% | 131.00K | Jul 09 | View |
| Jul 08, 2024 | Dr. Harrington | DIRECTOR | -253.00 | $54.61 | -$13.82K | SELL | -1.60% | 15.52K | Jul 05 | View |
| Jul 01, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $32.45 | -$217.70K | SELL-OPTIONS | 0.00% | 20.60K | Jul 01 | View |
| Jul 01, 2024 | Robert Blum | PRESIDENT & CEO | -11.50K | $54.05 | -$621.58K | SELL | -2.75% | 407.23K | Jul 01 | View |
| Jun 25, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $30.84 | -$349.95K | SELL | -1.48% | 133.00K | Jun 25 | View |
| Jun 17, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $31.61 | -$209.35K | SELL-OPTIONS | 0.00% | 20.60K | Jun 17 | View |
| Jun 17, 2024 | Robert Blum | PRESIDENT & CEO | -22.50K | $52.60 | -$1.18M | SELL | -5.10% | 418.73K | Jun 17 | View |
| Jun 11, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.37K | $30.50 | -$369.95K | SELL | -1.72% | 135.00K | Jun 11 | View |
| Jun 10, 2024 | Muna Bhanji | DIRECTOR | -2.00K | $52.07 | -$104.14K | SELL | -10.19% | 17.63K | Jun 10 | View |
| Jun 07, 2024 | Robert Blum | PRESIDENT & CEO | -22.50K | $48.85 | -$1.10M | SELL | -4.85% | 441.23K | Jun 04 | View |
| Jun 05, 2024 | Dr. Harrington | DIRECTOR | -1.58K | $48.64 | -$76.85K | SELL | -9.23% | 15.54K | Jun 03 | View |
| Jun 04, 2024 | LYNNE PARSHALL | DIRECTOR | 0.00 | $29.66 | -$189.80K | SELL-OPTIONS | 0.00% | 15.60K | Jun 03 | View |
| Jun 03, 2024 | Robert Wong | VP, CHIEF ACCOUNTING OFFICER | -13.01K | $48.88 | -$635.98K | SELL | -43.86% | 16.65K | Jun 03 | View |
| May 07, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -1.36K | $35.89 | -$917.64K | SELL | -0.98% | 137.06K | May 07 | View |
| Apr 25, 2024 | Dr. Henderson | DIRECTOR | -10.56K | $64.54 | -$681.67K | SELL | -24.73% | 32.15K | Apr 25 | View |
| Apr 09, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $40.49 | -$2.23M | SELL | -2.81% | 138.57K | Apr 09 | View |
| Mar 05, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $37.11 | -$2.01M | SELL | -2.80% | 138.97K | Mar 05 | View |
| Feb 14, 2024 | Dr. Henderson | DIRECTOR | 0.00 | $40.46 | -$360.20K | SELL-OPTIONS | 0.00% | 42.72K | Feb 14 | View |
| Feb 13, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $41.76 | -$877.25K | SELL-OPTIONS | 0.00% | 443.88K | Feb 13 | View |
| Feb 06, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $42.98 | -$2.39M | SELL | -2.72% | 142.97K | Feb 06 | View |
| Feb 02, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $43.12 | -$911.25K | SELL-OPTIONS | 0.00% | 443.88K | Jan 31 | View |
| Jan 22, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $44.05 | -$934.38K | SELL-OPTIONS | 0.00% | 443.88K | Jan 19 | View |
| Jan 12, 2024 | Dr. Henderson | DIRECTOR | 0.00 | $44.79 | -$403.50K | SELL-OPTIONS | 0.00% | 42.72K | Jan 12 | View |
| Jan 04, 2024 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $47.47 | -$1.27M | SELL | -2.65% | 146.97K | Jan 04 | View |
| Jan 02, 2024 | Robert Blum | PRESIDENT & CEO | 0.00 | $45.88 | -$980.13K | SELL-OPTIONS | 0.00% | 443.88K | Jan 02 | View |
| Dec 27, 2023 | Dr. Wierenga | DIRECTOR | 0.00 | $39.02 | -$691.60K | SELL-OPTIONS | 0.00% | 18.65K | Dec 27 | View |
| Dec 19, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $21.81 | -$378.50K | SELL-OPTIONS | 0.00% | 443.88K | Dec 18 | View |
| Dec 19, 2023 | Dr. Henderson | DIRECTOR | 10.56K | $21.53 | -$1.83K | SELL-OPTIONS | 33.11% | 42.46K | Dec 18 | View |
| Dec 01, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $19.83 | -$329.00K | SELL-OPTIONS | 0.00% | 443.50K | Nov 30 | View |
| Nov 15, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $20.62 | -$348.75K | SELL-OPTIONS | 0.00% | 443.50K | Nov 15 | View |
| Nov 09, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $35.40 | -$88.50K | SELL | -1.63% | 150.66K | Nov 09 | View |
| Oct 30, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $19.42 | -$318.75K | SELL-OPTIONS | 0.00% | 443.50K | Oct 30 | View |
| Oct 16, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $20.19 | -$337.88K | SELL-OPTIONS | 0.00% | 443.50K | Oct 16 | View |
| Oct 12, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $35.89 | -$89.72K | SELL | -1.61% | 153.16K | Oct 12 | View |
| Oct 06, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $18.34 | -$291.63K | SELL-OPTIONS | 0.00% | 443.50K | Oct 06 | View |
| Sep 14, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $34.86 | -$87.15K | SELL | -1.58% | 155.66K | Sep 14 | View |
| Sep 13, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $20.78 | -$352.83K | SELL-OPTIONS | 0.00% | 443.50K | Sep 13 | View |
| Aug 28, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $20.85 | -$328.60K | SELL-OPTIONS | 0.00% | 443.50K | Aug 25 | View |
| Aug 21, 2023 | Dr. Wierenga | DIRECTOR | 0.00 | $19.37 | -$152.31K | SELL-OPTIONS | 0.00% | 18.20K | Aug 21 | View |
| Aug 11, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.55 | -$628.04K | SELL-OPTIONS | 0.00% | 443.50K | Dec 21 - Aug 11 | View |
| Aug 10, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $31.70 | -$79.25K | SELL | -1.56% | 158.16K | Aug 10 | View |
| Aug 01, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $21.14 | -$287.23K | SELL-OPTIONS | 0.00% | 443.50K | Aug 01 | View |
| Jul 13, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $22.46 | -$320.31K | SELL-OPTIONS | 0.00% | 443.50K | Jul 13 | View |
| Jul 13, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $35.37 | -$88.42K | SELL | -1.53% | 160.66K | Jul 13 | View |
| Jul 07, 2023 | Muna Bhanji | DIRECTOR | -2.00K | $34.12 | -$68.23K | SELL | -12.48% | 14.03K | Jul 07 | View |
| Jul 05, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $21.13 | -$286.88K | SELL-OPTIONS | 0.00% | 443.50K | Jul 03 | View |
| Jun 12, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.36 | -$342.63K | SELL-OPTIONS | 0.00% | 443.50K | Jun 12 | View |
| Jun 08, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -2.50K | $38.07 | -$95.17K | SELL | -1.51% | 163.16K | Jun 08 | View |
| Jun 01, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.66 | -$350.25K | SELL-OPTIONS | 0.00% | 443.14K | May 31 | View |
| May 16, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.53 | -$347.00K | SELL-OPTIONS | 0.00% | 443.14K | May 16 | View |
| May 15, 2023 | Dr. Henderson | DIRECTOR | 0.00 | $22.28 | -$129.10K | SELL-OPTIONS | 0.00% | 25.50K | May 15 | View |
| May 11, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -1.79K | $39.50 | -$70.59K | SELL | -1.07% | 165.40K | May 11 | View |
| May 03, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $23.98 | -$224.28K | SELL-OPTIONS | 0.00% | 167.18K | May 03 | View |
| Apr 28, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.66 | -$350.38K | SELL-OPTIONS | 0.00% | 443.14K | Apr 28 | View |
| Apr 14, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $22.63 | -$324.50K | SELL-OPTIONS | 0.00% | 443.14K | Apr 14 | View |
| Apr 13, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $34.21 | -$136.84K | SELL | -2.34% | 167.18K | Apr 13 | View |
| Mar 28, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $22.35 | -$317.50K | SELL-OPTIONS | 0.00% | 443.14K | Mar 28 | View |
| Mar 17, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.45 | -$345.13K | SELL-OPTIONS | 0.00% | 443.14K | Mar 15 | View |
| Mar 09, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $39.10 | -$156.40K | SELL | -2.28% | 171.18K | Mar 09 | View |
| Mar 07, 2023 | Robert Blum | PRESIDENT & CEO | -11.90K | $24.60 | -$844.27K | SELL | -3.19% | 360.64K | Mar 06 | View |
| Feb 21, 2023 | Robert Wong | VP, CHIEF ACCOUNTING OFFICER | -2.23K | $45.21 | -$101.00K | SELL | -8.27% | 24.79K | Feb 21 | View |
| Feb 09, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $43.73 | -$174.92K | SELL | -2.55% | 152.59K | Feb 09 | View |
| Feb 09, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $25.85 | -$250.46K | SELL-OPTIONS | 0.00% | 156.59K | Feb 09 | View |
| Feb 08, 2023 | Dr. Wierenga | DIRECTOR | 0.00 | $25.86 | -$267.96K | SELL-OPTIONS | 0.00% | 12.53K | Feb 06 | View |
| Feb 07, 2023 | Ching Jaw | SVP FINANCE & CFO | 0.00 | $28.55 | -$493.50K | SELL-OPTIONS | 0.00% | 67.18K | Feb 03 | View |
| Feb 06, 2023 | Robert Wong | VP, CHIEF ACCOUNTING OFFICER | -3.00K | $45.00 | -$135.18K | SELL | -9.84% | 27.53K | Feb 03 | View |
| Jan 19, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $26.04 | -$327.80K | SELL-OPTIONS | 0.00% | 408.50K | Jan 17 | View |
| Jan 12, 2023 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $40.47 | -$161.88K | SELL | -2.49% | 156.59K | Jan 12 | View |
| Jan 06, 2023 | Robert Blum | PRESIDENT & CEO | 0.00 | $26.95 | -$345.90K | SELL-OPTIONS | 0.00% | 408.50K | Jan 04 | View |
| Dec 08, 2022 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $36.28 | -$145.12K | SELL | -2.43% | 160.59K | Dec 08 | View |
| Dec 05, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $24.47 | -$296.47K | SELL-OPTIONS | 0.00% | 408.50K | Dec 05 | View |
| Nov 23, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $25.27 | -$312.40K | SELL-OPTIONS | 0.00% | 408.17K | Nov 21 | View |
| Nov 15, 2022 | Robert Wong | VP, CHIEF ACCOUNTING OFFICER | -2.10K | $40.68 | -$85.43K | SELL | -6.43% | 30.54K | Nov 14 | View |
| Nov 10, 2022 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | -4.00K | $38.04 | -$152.16K | SELL | -2.38% | 164.35K | Nov 10 | View |
| Nov 04, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $25.13 | -$340.76K | SELL-OPTIONS | 0.00% | 408.17K | Nov 02 | View |
| Oct 21, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $27.91 | -$399.00K | SELL-OPTIONS | 0.00% | 408.17K | Oct 19 | View |
| Oct 13, 2022 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $28.46 | -$809.53K | SELL-OPTIONS | 0.00% | 168.35K | Oct 13 | View |
| Oct 05, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $29.18 | -$424.40K | SELL-OPTIONS | 0.00% | 408.17K | Oct 03 | View |
| Sep 21, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $29.69 | -$434.60K | SELL-OPTIONS | 0.00% | 408.17K | Sep 19 | View |
| Sep 12, 2022 | Dr. Henderson | DIRECTOR | 0.00 | $29.48 | -$1.11M | SELL-OPTIONS | 0.00% | 24.13K | Sep 12 | View |
| Sep 09, 2022 | Dr. Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $30.77 | -$907.95K | SELL-OPTIONS | 0.00% | 168.35K | Sep 08 | View |
| Sep 09, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $28.54 | -$411.50K | SELL-OPTIONS | 0.00% | 408.17K | Sep 07 | View |
| Sep 02, 2022 | SANDFORD SMITH | DIRECTOR | 0.00 | $38.82 | -$344.56K | SELL-OPTIONS | 0.00% | 12.17K | Sep 02 | View |
| Sep 01, 2022 | LYNNE PARSHALL | DIRECTOR | 0.00 | $30.86 | -$1.33M | SELL-OPTIONS | 0.00% | 10.00K | Sep 01 | View |
| Sep 01, 2022 | SANTO COSTA | DIRECTOR | 0.00 | $31.53 | -$637.80K | SELL-OPTIONS | 0.00% | 10.00K | Sep 01 | View |
| Sep 01, 2022 | Dr. Wierenga | DIRECTOR | 0.00 | $29.79 | -$191.68K | SELL-OPTIONS | 0.00% | 12.17K | Sep 01 | View |
| Aug 19, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $29.04 | -$421.50K | SELL-OPTIONS | 0.00% | 411.21K | Aug 17 | View |
| Aug 08, 2022 | Dr. Kaye | DIRECTOR | 0.00 | $29.38 | -$471.40K | SELL-OPTIONS | 0.00% | 12.58K | Aug 05 | View |
| Aug 03, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $24.61 | -$333.00K | SELL-OPTIONS | 0.00% | 411.21K | Aug 01 | View |
| Jul 20, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $24.23 | -$325.30K | SELL-OPTIONS | 0.00% | 411.56K | Jul 18 | View |
| Jul 14, 2022 | Ibraham Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $26.54 | -$726.27K | SELL-OPTIONS | 0.00% | 168.35K | Jul 14 | View |
| Jul 08, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $26.17 | -$364.20K | SELL-OPTIONS | 0.00% | 411.56K | Jul 06 | View |
| Jun 17, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $23.68 | -$314.40K | SELL-OPTIONS | 0.00% | 411.56K | Jun 15 | View |
| Jun 10, 2022 | Ibraham Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $25.13 | -$665.86K | SELL-OPTIONS | 0.00% | 168.35K | Jun 09 | View |
| Jun 08, 2022 | Robert Blum | PRESIDENT & CEO | 0.00 | $24.59 | -$332.70K | SELL-OPTIONS | 0.00% | 411.56K | Jun 06 | View |
| May 18, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $25.53 | -$351.46K | SELL-OPTIONS | 0.00% | 411.21K | May 16 | View |
| May 12, 2022 | Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $23.60 | -$390.10K | SELL-OPTIONS | 0.00% | 168.08K | May 12 | View |
| May 06, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $23.70 | -$314.72K | SELL-OPTIONS | 0.00% | 411.21K | May 04 | View |
| Apr 22, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $22.92 | -$299.27K | SELL-OPTIONS | 0.00% | 411.21K | Apr 20 | View |
| Apr 07, 2022 | Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $24.29 | -$846.87K | SELL-OPTIONS | 0.00% | 168.08K | Apr 07 | View |
| Apr 06, 2022 | Ching Jaw | SVP FINANCE & CFO | 0.00 | $26.45 | -$717.50K | SELL-OPTIONS | 0.00% | 67.11K | Apr 04 - Apr 05 | View |
| Apr 06, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $23.37 | -$308.23K | SELL-OPTIONS | 0.00% | 411.21K | Apr 04 | View |
| Mar 23, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $22.00 | -$280.74K | SELL-OPTIONS | 0.00% | 411.21K | Mar 21 | View |
| Mar 15, 2022 | Mark Schlossberg | SVP - LEGAL & GENERAL COUNSEL | 35.62K | $22.31 | -$207.09K | SELL-OPTIONS | 52.55% | 103.41K | Mar 15 | View |
| Mar 10, 2022 | Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $21.91 | -$854.35K | SELL-OPTIONS | 0.00% | 168.08K | Mar 10 | View |
| Mar 09, 2022 | Ching Jaw | SVP FINANCE & CFO | 0.00 | $25.05 | -$388.50K | SELL-OPTIONS | 0.00% | 67.11K | Mar 09 | View |
| Mar 04, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $22.14 | -$283.54K | SELL-OPTIONS | 0.00% | 435.01K | Mar 02 | View |
| Mar 02, 2022 | Santo J Costa | DIRECTOR | 0.00 | $24.01 | -$266.68K | SELL-OPTIONS | 0.00% | 5.00K | Mar 02 | View |
| Feb 18, 2022 | Robert I Blum | PRESIDENT & CEO | 14.47K | $22.23 | -$285.37K | SELL-OPTIONS | 3.99% | 377.20K | Feb 16 | View |
| Feb 09, 2022 | Robert I Blum | PRESIDENT & CEO | 0.00 | $20.91 | -$258.99K | SELL-OPTIONS | 0.00% | 362.73K | Feb 07 | View |
| Dec 28, 2021 | Wendell Wierenga | DIRECTOR | 0.00 | $24.92 | -$162.11K | SELL-OPTIONS | 0.00% | 6.76K | Dec 27 | View |
| Dec 28, 2021 | Sandford D Smith | DIRECTOR | 0.00 | $33.45 | -$698.25K | SELL-OPTIONS | 0.00% | 6.76K | Dec 27 | View |
| Dec 23, 2021 | Edward M. Kaye | DIRECTOR | 0.00 | $26.30 | -$560.85K | SELL-OPTIONS | 0.00% | 6.76K | Dec 23 | View |
| Dec 09, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $21.40 | -$880.54K | SELL-OPTIONS | 0.00% | 149.31K | Dec 09 | View |
| Nov 19, 2021 | Sandford D Smith | DIRECTOR | 0.00 | $27.19 | -$814.03K | SELL-OPTIONS | 0.00% | 6.76K | Nov 19 | View |
| Nov 12, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $22.81 | -$139.31K | SELL-OPTIONS | 0.00% | 362.15K | Nov 12 | View |
| Nov 12, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $39.56 | -$79.12K | SELL | -1.33% | 148.88K | Nov 11 | View |
| Nov 09, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | 0.00 | $25.71 | -$1.44M | SELL-OPTIONS | 0.00% | 138.70K | Nov 09 | View |
| Nov 08, 2021 | L. Patrick Gage | DIRECTOR | 0.00 | $22.79 | -$981.62K | SELL-OPTIONS | 0.00% | 30.78K | Nov 08 | View |
| Nov 05, 2021 | John T Henderson | DIRECTOR | 0.00 | $22.94 | -$290.12K | SELL-OPTIONS | 0.00% | 13.34K | Nov 05 | View |
| Nov 05, 2021 | B. Lynne Parshall | DIRECTOR | 0.00 | $26.17 | -$857.46K | SELL-OPTIONS | 0.00% | 5.00K | Nov 05 | View |
| Nov 02, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | 0.00 | $20.44 | -$722.24K | SELL-OPTIONS | 0.00% | 138.70K | Nov 01 | View |
| Nov 02, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $20.90 | -$149.00K | SELL-OPTIONS | 0.00% | 362.15K | Oct 29 | View |
| Oct 21, 2021 | Ching Jaw | SVP FINANCE & CFO | -35.69K | $35.73 | -$1.28M | SELL | -40.21% | 53.06K | Oct 19 | View |
| Oct 20, 2021 | Mark Schlossberg | SVP - LEGAL & GENERAL COUNSEL | 0.00 | $21.38 | -$573.52K | SELL-OPTIONS | 0.00% | 50.85K | Oct 19 | View |
| Oct 20, 2021 | Lynne Parshall | DIRECTOR | 0.00 | $21.19 | -$300.54K | SELL-OPTIONS | 0.00% | 5.00K | Oct 19 | View |
| Oct 15, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $21.87 | -$158.71K | SELL-OPTIONS | 0.00% | 359.65K | Oct 14 | View |
| Oct 14, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $37.73 | -$75.45K | SELL | -1.31% | 150.88K | Oct 14 | View |
| Oct 01, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | -7.57K | $35.14 | -$265.99K | SELL | -5.23% | 137.12K | Oct 01 | View |
| Oct 01, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $20.01 | -$140.06K | SELL-OPTIONS | 0.00% | 359.65K | Sep 30 | View |
| Sep 17, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $19.45 | -$132.10K | SELL-OPTIONS | 0.00% | 359.65K | Sep 15 | View |
| Sep 09, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $31.43 | -$62.86K | SELL | -1.29% | 152.88K | Sep 09 | View |
| Sep 03, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $19.71 | -$134.08K | SELL-OPTIONS | 0.00% | 359.65K | Sep 02 | View |
| Sep 02, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | -7.85K | $32.78 | -$257.31K | SELL | -5.15% | 144.69K | Sep 01 | View |
| Aug 20, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $18.72 | -$124.21K | SELL-OPTIONS | 0.00% | 359.65K | Aug 18 | View |
| Aug 13, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $32.60 | -$65.20K | SELL | -1.27% | 154.88K | Aug 12 | View |
| Aug 06, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $17.71 | -$114.10K | SELL-OPTIONS | 0.00% | 359.65K | Aug 05 | View |
| Aug 02, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | -2.62K | $29.67 | -$77.62K | SELL | -1.69% | 152.54K | Aug 02 | View |
| Jul 23, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $18.06 | -$117.62K | SELL-OPTIONS | 0.00% | 359.65K | Jul 22 | View |
| Jul 21, 2021 | Sandford Smith | DIRECTOR | 0.00 | $19.78 | -$217.68K | SELL-OPTIONS | 0.00% | 6.46K | Jul 19 | View |
| Jul 08, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $19.48 | -$38.95K | SELL | -1.26% | 156.88K | Jul 08 | View |
| Jul 06, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $13.22 | -$69.17K | SELL-OPTIONS | 0.00% | 359.65K | Jul 06 | View |
| Jul 02, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | -6.01K | $19.87 | -$119.48K | SELL | -3.73% | 155.16K | Jul 01 | View |
| Jun 21, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $13.83 | -$75.34K | SELL-OPTIONS | 0.00% | 359.65K | Jun 18 | View |
| Jun 10, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $21.48 | -$42.95K | SELL | -1.24% | 158.88K | Jun 10 | View |
| Jun 04, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $13.45 | -$71.54K | SELL-OPTIONS | 0.00% | 359.65K | Jun 03 | View |
| Jun 02, 2021 | David Cragg | CHIEF HR & ADMIN OFFICER | 0.00 | $13.96 | -$229.90K | SELL-OPTIONS | 0.00% | 161.17K | Jun 01 | View |
| May 24, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $15.00 | -$87.05K | SELL-OPTIONS | 0.00% | 358.94K | May 20 | View |
| May 13, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $24.42 | -$48.84K | SELL | -1.23% | 160.35K | May 13 | View |
| May 07, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $14.75 | -$84.54K | SELL-OPTIONS | 0.00% | 358.94K | May 07 | View |
| Apr 30, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $16.09 | -$97.86K | SELL-OPTIONS | 0.00% | 358.94K | Apr 30 | View |
| Apr 27, 2021 | Sandford Smith | DIRECTOR | 0.00 | $19.19 | -$166.93K | SELL-OPTIONS | 0.00% | 920.00 | Apr 27 | View |
| Apr 27, 2021 | Sandford Smith | DIRECTOR | 0.00 | $18.23 | -$87.75K | SELL-OPTIONS | 0.00% | 920.00 | Apr 26 | View |
| Apr 23, 2021 | Sandford Smith | DIRECTOR | 0.00 | $17.98 | -$85.25K | SELL-OPTIONS | 0.00% | 920.00 | Apr 23 | View |
| Apr 15, 2021 | Sandford Smith | DIRECTOR | 0.00 | $17.16 | -$173.10K | SELL-OPTIONS | 0.00% | 920.00 | Apr 15 | View |
| Apr 12, 2021 | Robert Blum | PRESIDENT & CEO | 0.00 | $14.93 | -$86.31K | SELL-OPTIONS | 0.00% | 358.94K | Apr 12 | View |
| Apr 12, 2021 | Sanford Smith | DIRECTOR | 0.00 | $15.91 | -$442.17K | SELL-OPTIONS | 0.00% | 920.00 | Apr 09 | View |
| Apr 08, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $23.39 | -$46.77K | SELL | -1.22% | 162.35K | Apr 08 | View |
| Apr 05, 2021 | John T Henderson | DIRECTOR | 0.00 | $16.09 | -$49.68K | SELL-OPTIONS | 0.00% | 7.49K | Apr 01 | View |
| Mar 24, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $15.61 | -$95.80K | SELL-OPTIONS | 0.00% | 358.94K | Mar 22 | View |
| Mar 19, 2021 | Patrick Gage | DIRECTOR | 0.00 | $15.16 | -$185.67K | SELL-OPTIONS | 0.00% | 23.61K | Mar 19 | View |
| Mar 12, 2021 | Patrick Gage | DIRECTOR | 0.00 | $13.99 | -$149.38K | SELL-OPTIONS | 0.00% | 23.61K | Mar 12 | View |
| Mar 11, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -2.00K | $19.90 | -$39.80K | SELL | -1.20% | 164.35K | Mar 11 | View |
| Mar 08, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $12.75 | -$67.47K | SELL-OPTIONS | 0.00% | 382.74K | Mar 08 | View |
| Feb 26, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $12.67 | -$66.65K | SELL-OPTIONS | 0.00% | 336.46K | Feb 26 | View |
| Feb 12, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.63K | $23.34 | -$38.10K | SELL | -1.08% | 148.81K | Feb 11 | View |
| Feb 12, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $14.94 | -$89.38K | SELL-OPTIONS | 0.00% | 307.67K | Feb 10 | View |
| Jan 29, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $13.17 | -$71.70K | SELL-OPTIONS | 0.00% | 307.67K | Jan 29 | View |
| Jan 22, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $13.20 | -$72.04K | SELL-OPTIONS | 0.00% | 307.67K | Jan 20 | View |
| Jan 15, 2021 | Fady Malik | EVP RESEARCH & DEVELOPMENT | 0.00 | $14.33 | -$122.87K | SELL-OPTIONS | 0.00% | 150.44K | Jan 14 | View |
| Jan 04, 2021 | Robert I Blum | PRESIDENT & CEO | 0.00 | $13.11 | -$71.14K | SELL-OPTIONS | 0.00% | 307.67K | Jan 04 | View |
| Dec 31, 2020 | John T Henderson | — | 0.00 | $16.63 | -$6.31K | OPTION EXERCISE | 0.00% | 982.00 | Dec 31 | View |
| Dec 18, 2020 | Robert I Blum | — | 0.00 | $13.26 | -$72.55K | OPTION EXERCISE | 0.00% | 307.67K | Dec 16 | View |
| Dec 15, 2020 | Patrick Gage | — | 0.00 | $16.98 | -$62.04K | OPTION EXERCISE | 0.00% | 22.65K | Dec 15 | View |
| Dec 11, 2020 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | — | -430.95K | $18.00 | -$7.76M | SELL | -48.19% | 463.24K | Dec 09 | View |
| Dec 10, 2020 | Fady Malik | — | -1.05K | $20.13 | -$21.18K | SELL | -0.69% | 150.44K | Dec 10 | View |
| Dec 04, 2020 | Robert I Blum | — | 0.00 | $11.68 | -$56.80K | OPTION EXERCISE | 0.00% | 307.67K | Dec 04 | View |
| Nov 25, 2020 | Robert I Blum | — | 0.00 | $10.86 | -$48.64K | OPTION EXERCISE | 0.00% | 306.95K | Nov 23 | View |
| Nov 16, 2020 | Fady Malik | — | -1.23K | $17.15 | -$21.11K | SELL | -0.81% | 150.95K | Nov 12 | View |
| Nov 12, 2020 | Robert I Blum | — | 0.00 | $11.25 | -$52.49K | OPTION EXERCISE | 0.00% | 306.95K | Nov 10 | View |
| Oct 30, 2020 | Robert I Blum | — | 0.00 | $10.58 | -$45.77K | OPTION EXERCISE | 0.00% | 306.95K | Oct 29 | View |
| Oct 14, 2020 | Robert I Blum | — | 0.00 | $10.97 | -$49.69K | OPTION EXERCISE | 0.00% | 306.95K | Oct 13 | View |
| Oct 08, 2020 | Fady Malik | — | -1.26K | $17.45 | -$21.95K | SELL | -0.82% | 152.18K | Oct 08 | View |
| Oct 06, 2020 | Lynne Parshall | — | 0.00 | $18.62 | -$1.15M | OPTION EXERCISE | 0.00% | 0.00 | Oct 05 | View |
| Oct 05, 2020 | Sandford D Smith | — | 0.00 | $18.68 | -$134.33K | OPTION EXERCISE | 0.00% | 0.00 | Oct 05 | View |
| Oct 05, 2020 | John T Henderson | — | 0.00 | $20.98 | -$48.12K | OPTION EXERCISE | 0.00% | 982.00 | Oct 05 | View |
| Oct 05, 2020 | Edward Kaye | — | 0.00 | $18.80 | -$447.80K | OPTION EXERCISE | 0.00% | 0.00 | Oct 05 | View |
| Oct 05, 2020 | Ching Jaw | — | 0.00 | $20.01 | -$549.30K | OPTION EXERCISE | 0.00% | 73.30K | Oct 05 | View |
| Oct 05, 2020 | Santo J Costa | — | 0.00 | $19.73 | -$308.25K | OPTION EXERCISE | 0.00% | 0.00 | Oct 05 | View |
| Oct 02, 2020 | Robert I Blum | — | 0.00 | $14.26 | -$82.65K | OPTION EXERCISE | 0.00% | 306.95K | Oct 02 | View |
| Sep 21, 2020 | Robert I Blum | — | 0.00 | $13.48 | -$74.83K | OPTION EXERCISE | 0.00% | 306.95K | Sep 21 | View |
| Sep 11, 2020 | Robert I Blum | — | 0.00 | $14.47 | -$84.74K | OPTION EXERCISE | 0.00% | 306.95K | Sep 11 | View |
| Sep 11, 2020 | Fady Malik | — | -995.00 | $22.85 | -$22.74K | SELL | -0.64% | 153.44K | Sep 10 | View |
| Sep 04, 2020 | Robert I Blum | — | 0.00 | $14.19 | -$81.85K | OPTION EXERCISE | 0.00% | 306.95K | Sep 04 | View |
| Aug 21, 2020 | Ching Jaw | — | 0.00 | $16.27 | -$436.60K | OPTION EXERCISE | 0.00% | 73.30K | Aug 21 | View |
| Aug 21, 2020 | Mark Schlossberg | — | 0.00 | $16.02 | -$179.70K | OPTION EXERCISE | 0.00% | 30.00K | Aug 21 | View |
| Aug 20, 2020 | Robert I Blum | — | 0.00 | $14.74 | -$87.42K | OPTION EXERCISE | 0.00% | 306.95K | Aug 18 | View |
| Aug 14, 2020 | Fady Malik | — | -599.00 | $21.85 | -$13.09K | SELL | -0.39% | 154.44K | Aug 13 | View |
| Aug 07, 2020 | Robert I Blum | — | 0.00 | $14.06 | -$80.62K | OPTION EXERCISE | 0.00% | 306.95K | Aug 05 | View |
| Jul 30, 2020 | Mark Schlossberg | — | 0.00 | $15.05 | -$160.43K | OPTION EXERCISE | 0.00% | 30.00K | Jul 29 | View |
| Jul 30, 2020 | Robert I Blum | — | 0.00 | $14.88 | -$88.83K | OPTION EXERCISE | 0.00% | 306.95K | Jul 28 | View |
| Jul 17, 2020 | Robert I Blum | — | 0.00 | $16.68 | -$106.81K | OPTION EXERCISE | 0.00% | 306.95K | Jul 16 | View |
| Jul 17, 2020 | Sandford D Smith | — | 0.00 | $17.61 | -$151.94K | OPTION EXERCISE | 0.00% | 0.00 | Jul 15 | View |
| Jul 13, 2020 | Sandford D Smith | — | 0.00 | $17.11 | -$145.27K | OPTION EXERCISE | 0.00% | 0.00 | Jul 10 | View |
| Jul 10, 2020 | Fady Malik | — | -1.59K | $26.96 | -$42.79K | SELL | -1.01% | 155.03K | Jul 09 | View |
| Jul 09, 2020 | Sandford D Smith | — | 0.00 | $16.48 | -$264.10K | OPTION EXERCISE | 0.00% | 0.00 | Jul 07 - Jul 08 | View |
| Jul 08, 2020 | Robert I Blum | — | 0.00 | $15.43 | -$94.25K | OPTION EXERCISE | 0.00% | 306.95K | Jul 06 | View |
| Jun 26, 2020 | Robert I Blum | — | 0.00 | $14.97 | -$88.95K | OPTION EXERCISE | 0.00% | 306.95K | Jun 24 | View |
| Jun 24, 2020 | Santo J Costa | — | 0.00 | $16.30 | -$347.80K | OPTION EXERCISE | 0.00% | 0.00 | Jun 22 | View |
| Jun 23, 2020 | B. Lynne Parshall | — | 0.00 | $15.17 | -$324.60K | OPTION EXERCISE | 0.00% | 0.00 | Jun 22 | View |
| Jun 22, 2020 | Sandford D Smith | — | 0.00 | $14.47 | -$200.60K | OPTION EXERCISE | 0.00% | 0.00 | Jun 22 | View |
| Jun 17, 2020 | Sandford D Smith | — | 0.00 | $14.90 | -$111.87K | OPTION EXERCISE | 0.00% | 0.00 | Jun 17 | View |
| Jun 15, 2020 | Sandford D Smith | — | 0.00 | $14.15 | -$104.66K | OPTION EXERCISE | 0.00% | 0.00 | Jun 15 | View |
| Jun 12, 2020 | Robert I Blum | — | 0.00 | $13.89 | -$75.85K | OPTION EXERCISE | 0.00% | 306.95K | Jun 11 | View |
| Jun 12, 2020 | Sanford D. Smith | — | 0.00 | $12.64 | -$247.43K | OPTION EXERCISE | 0.00% | 0.00 | Jun 12 | View |
| May 29, 2020 | Robert I Blum | — | 0.00 | $13.20 | -$69.00K | OPTION EXERCISE | 0.00% | 305.72K | May 29 | View |
| May 18, 2020 | Robert I Blum | — | -811.00 | $14.22 | -$84.34K | OPTION EXERCISE | -0.26% | 305.72K | May 18 | View |
| May 12, 2020 | Santo J Costa | — | 0.00 | $14.16 | -$340.10K | OPTION EXERCISE | 0.00% | 0.00 | May 11 | View |
| May 06, 2020 | Santo J Costa | — | 0.00 | $11.56 | -$90.65K | OPTION EXERCISE | 0.00% | 0.00 | May 05 | View |
| May 01, 2020 | Robert I Blum | — | -5.00K | $14.34 | -$71.68K | SELL | -1.60% | 306.53K | May 01 | View |
| Apr 29, 2020 | Wendell Wierenga | — | 0.00 | $13.12 | -$57.59K | OPTION EXERCISE | 0.00% | 0.00 | Apr 28 | View |
| Mar 20, 2020 | Patrick L. Gage | — | -8.00K | $14.82 | -$118.59K | SELL | -26.80% | 21.85K | Mar 06 | View |
| Feb 18, 2020 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBIOTECHNOLOGY VALUE FUND II LPBiotechnology Value Trading Fund OS LPBVF Partners OS LtdINCIL BVFMARK LAMPERT | — | -1.07M | $15.79 | -$16.92M | SELL | -71.64% | 424.42K | Feb 13 | View |
| Jan 16, 2020 | Robert I Blum | — | -4.95K | $12.96 | -$64.16K | SELL | -2.14% | 226.19K | Jan 15 | View |
| Jan 02, 2020 | John Henderson | — | 6.00K | $8.57 | $51.43K | PURCHASE | 1801.80% | 6.33K | Nov 19 | View |
| Dec 17, 2019 | Robert I Blum | PRESIDENT & CEO | -6.00K | $10.22 | -$61.33K | SELL | -2.53% | 231.14K | Dec 16 | View |
| Dec 12, 2019 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBIOTECHNOLOGY VALUE FUND II LPBiotechnology Value Trading Fund OS LPBVF Partners OS LtdINCIL BVFMARK LAMPERT | 10% OWNER | 342.07K | $9.44 | $3.23M | BUY | 217.55% | 499.31K | Dec 10 - Dec 11 | View |
| Dec 06, 2019 | Fady Malik M.D., Ph.D. | EVP RESEARCH & DEVELOPMENT | -1.50K | $9.80 | -$14.70K | SELL | -1.22% | 121.35K | Dec 05 | View |
| Nov 18, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $8.08 | -$48.51K | SELL | -2.47% | 237.14K | Nov 15 | View |
| Nov 08, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $9.98 | -$14.97K | SELL | -1.21% | 122.85K | Nov 07 | View |
| Oct 16, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $11.16 | -$66.97K | SELL | -2.44% | 240.10K | Oct 15 | View |
| Oct 04, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $11.22 | -$16.83K | SELL | -1.21% | 122.07K | Oct 03 | View |
| Sep 17, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $12.74 | -$76.47K | SELL | -2.38% | 246.10K | Sep 16 | View |
| Sep 06, 2019 | Fady Malik M.D., Ph.D | EVP RESEARCH & DEVELOPMENT | -1.50K | $13.69 | -$20.53K | SELL | -1.20% | 123.57K | Sep 05 | View |
| Aug 16, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $12.64 | -$75.81K | SELL | -2.32% | 252.10K | Aug 15 | View |
| Aug 09, 2019 | Fady Malik M.D., Ph.D. | EVP RESEARCH & DEVELOPMENT | -1.50K | $13.52 | -$20.28K | SELL | -1.19% | 125.07K | Aug 08 | View |
| Jul 16, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $10.94 | -$65.63K | SELL | -2.27% | 258.11K | Jul 15 | View |
| Jul 12, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $11.26 | -$16.89K | SELL | -1.17% | 126.57K | Jul 11 | View |
| Jun 19, 2019 | Robert Blum | PRESIDENT & CEO | -6.00K | $9.71 | -$58.24K | SELL | -2.22% | 264.11K | Jun 17 | View |
| Jun 07, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $10.31 | -$15.46K | SELL | -1.16% | 128.07K | Jun 06 | View |
| May 03, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $8.29 | -$12.43K | SELL | -1.14% | 129.57K | May 02 | View |
| Apr 05, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $8.31 | -$12.46K | SELL | -1.13% | 131.07K | Apr 04 | View |
| Mar 08, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $5.98 | -$8.97K | SELL | -1.12% | 132.57K | Mar 07 | View |
| Feb 08, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $7.28 | -$10.92K | SELL | -1.75% | 84.07K | Feb 07 | View |
| Jan 11, 2019 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $7.31 | -$10.96K | SELL | -1.72% | 85.57K | Jan 10 | View |
| Jan 04, 2019 | Robert Blum | PRESIDENT & CEO | -4.00K | $7.11 | -$28.43K | SELL | -2.60% | 150.10K | Jan 04 | View |
| Dec 07, 2018 | Robert Blum | PRESIDENT & CEO | -4.00K | $7.50 | -$29.99K | SELL | -2.53% | 154.10K | Dec 06 | View |
| Dec 07, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $7.38 | -$11.07K | SELL | -1.69% | 87.07K | Dec 06 | View |
| Nov 06, 2018 | Robert Blum | PRESIDENT & CEO | -4.00K | $7.11 | -$28.45K | SELL | -2.47% | 158.10K | Nov 05 | View |
| Nov 02, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $6.68 | -$10.02K | SELL | -1.67% | 88.57K | Nov 01 | View |
| Oct 05, 2018 | Robert Blum | PRESIDENT & CEO | -4.00K | $8.79 | -$35.18K | SELL | -2.41% | 162.10K | Oct 05 | View |
| Oct 05, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $9.14 | -$13.71K | SELL | -1.64% | 90.07K | Oct 04 | View |
| Sep 07, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $8.00 | -$12.00K | SELL | -1.61% | 91.57K | Sep 06 | View |
| Sep 07, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $7.94 | -$31.77K | SELL | -2.35% | 166.10K | Sep 05 | View |
| Aug 03, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $6.65 | -$26.58K | SELL | -2.30% | 170.10K | Aug 03 | View |
| Aug 03, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $6.85 | -$10.28K | SELL | -1.59% | 93.07K | Aug 02 | View |
| Jul 06, 2018 | Fady Malik | EVP RESEARCH & DEVELOPMENT | -1.50K | $9.05 | -$13.58K | SELL | -1.56% | 94.57K | Jul 05 | View |
| Jul 06, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $9.09 | -$36.37K | SELL | -2.25% | 174.10K | Jul 05 | View |
| Jun 07, 2018 | Malik M.D., Ph.D., Fady | EVP RESEARCH & DEVELOPMENT | -3.00K | $8.95 | -$26.85K | SELL | -3.03% | 96.07K | Jun 07 | View |
| Jun 05, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $8.28 | -$33.12K | SELL | -2.20% | 178.10K | Jun 05 | View |
| May 04, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $8.38 | -$33.51K | SELL | -2.15% | 182.10K | May 04 | View |
| Apr 06, 2018 | Robert I Blum | PRESIDENT & CEO | -4.00K | $7.52 | -$30.09K | SELL | -2.12% | 184.78K | Apr 05 | View |
| Jan 18, 2018 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | 0.00 | $7.77 | -$6.69K | SELL-OPTIONS | 0.00% | 15.00K | Jan 16 | View |
| Nov 06, 2017 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | -2.90K | $9.74 | -$46.28K | SELL | -16.22% | 15.00K | Nov 02 | View |
| Nov 03, 2017 | Fady Malik M.D., Ph.D. | EVP RESEARCH & DEVELOPMENT | -655.00 | $12.25 | -$24.05K | SELL | -1.40% | 46.19K | Nov 01 | View |
| Nov 03, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $13.51 | -$67.55K | SELL | -6.87% | 67.76K | Nov 01 | View |
| Oct 10, 2017 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | -1.60K | $11.00 | -$128.81K | SELL | -8.70% | 16.77K | Oct 06 | View |
| Oct 04, 2017 | L. Patrick Gage | DIRECTOR | 0.00 | $9.30 | -$52.84K | SELL-OPTIONS | 0.00% | 31.85K | Oct 02 | View |
| Oct 04, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $14.59 | -$72.96K | SELL | -6.50% | 71.97K | Oct 02 | View |
| Sep 08, 2017 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | -100.00 | $15.00 | -$1.50K | SELL | -0.54% | 18.37K | Sep 06 | View |
| Sep 08, 2017 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | 100.00 | $10.55 | -$81.34K | SELL-OPTIONS | 0.54% | 18.47K | Sep 06 | View |
| Sep 01, 2017 | L. Patrick Gage | DIRECTOR | 0.00 | $9.37 | -$53.52K | SELL-OPTIONS | 0.00% | 31.85K | Sep 01 | View |
| Sep 01, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $14.71 | -$73.53K | SELL | -6.10% | 76.97K | Sep 01 | View |
| Sep 01, 2017 | Santo J Costa | DIRECTOR | 0.00 | $9.72 | -$52.80K | SELL-OPTIONS | 0.00% | 0.00 | Aug 31 | View |
| Sep 01, 2017 | Bradley Morgan | SVP DRUG DISCOVERY & EARLY DEV | 0.00 | $11.42 | -$847.01K | SELL-OPTIONS | 0.00% | 46.44K | Aug 31 | View |
| Aug 30, 2017 | L. Patrick Gage | DIRECTOR | 0.00 | $9.01 | -$49.90K | SELL-OPTIONS | 0.00% | 31.85K | Aug 29 | View |
| Aug 30, 2017 | Santo J Costa | DIRECTOR | 0.00 | $9.22 | -$47.80K | SELL-OPTIONS | 0.00% | 0.00 | Aug 29 | View |
| Aug 10, 2017 | Caryn McDowell | GC & CHIEF COMPLIANCE OFFICER | -1.81K | $9.48 | -$79.47K | SELL | -8.97% | 18.37K | Aug 08 | View |
| Aug 02, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $13.79 | -$68.95K | SELL | -5.75% | 81.97K | Aug 01 | View |
| Jul 05, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $12.14 | -$60.69K | SELL | -5.44% | 86.97K | Jul 03 | View |
| Jun 02, 2017 | Robert I Blum | PRESIDENT & CEO | -5.00K | $13.62 | -$68.09K | SELL | -5.16% | 91.97K | Jun 01 | View |
| Dec 30, 2016 | Fady Malik M.D., Ph.D. | EVP RESEARCH & DEVELOPMENT | -5.63K | $12.36 | -$69.64K | SELL | -99.38% | 35.00 | Dec 28 - Dec 29 | View |
| Sep 01, 2015 | L. Patrick Gage | DIRECTOR | 1.00K | $6.95 | $6.95K | BUY | 3.24% | 31.85K | Aug 31 | View |
| Aug 21, 2015 | L. Patrick Gage | DIRECTOR | 10.00K | $6.55 | $65.49K | BUY | 47.96% | 30.85K | Aug 20 | View |
| May 08, 2015 | L. Patrick Gage | DIRECTOR | 10.00K | $5.71 | $57.12K | BUY | 92.17% | 20.85K | May 06 | View |
| Mar 13, 2015 | Andrew A Wolff | SVP & CMO | 0.00 | $7.05 | -$32.83K | SELL-OPTIONS | 0.00% | 21.26K | Mar 11 | View |
| Dec 31, 2014 | Fady Malik M.D., Ph.D. | SVP RESEARCH & DEVELOPMENT | -21.63K | $6.73 | -$145.68K | SELL | -86.55% | 3.36K | Dec 30 | View |
| May 12, 2014 | L. Patrick Gage | DIRECTOR | 10.85K | $4.09 | $44.38K | BUY | ∞ | 850.00 | May 09 | View |
| Feb 27, 2014 | Eastern Capital LTDPortfolio Services LtdBRYAN KENNETH DART | 10% OWNER | 500.00K | $8.00 | $4.00M | BUY | 20.97% | 2.88M | Feb 25 | View |
| Nov 16, 2012 | STEPHEN DOW | DIRECTOR | -1.74M | $0.61 | -$1.06M | SELL | -52.67% | 1.57M | Nov 14 | View |
| Jun 04, 2010 | James H Sabry | — | 0.00 | $1.75 | -$58.44K | SELL-OPTIONS | 0.00% | 0.00 | Jun 03 | View |
| Jun 04, 2010 | Michael Schmertzler | DIRECTOR | -5.38K | $3.00 | -$16.15K | SELL | -0.12% | 4.34M | Jun 03 | View |
| May 28, 2010 | Michael Schmertzler | DIRECTOR | -57.61K | $3.00 | -$172.82K | SELL | -1.31% | 4.35M | May 27 | View |
| May 20, 2010 | Michael Schmertzler | DIRECTOR | -16.24K | $3.00 | -$48.72K | SELL | -0.37% | 4.40M | May 19 | View |
| May 20, 2010 | James H Sabry | — | 0.00 | $1.80 | -$60.75K | SELL-OPTIONS | 0.00% | 0.00 | May 18 | View |
| May 19, 2010 | Michael Schmertzler | DIRECTOR | -414.59K | $3.00 | -$1.24M | SELL | -8.58% | 4.42M | May 18 | View |
| May 14, 2010 | James H Sabry | — | 0.00 | $2.10 | -$18.00K | SELL-OPTIONS | 0.00% | 0.00 | May 12 | View |
| May 13, 2010 | Michael Schmertzler | DIRECTOR | -82.74K | $3.00 | -$248.21K | SELL | -1.68% | 4.83M | May 12 | View |
| May 13, 2010 | Michael Schmertzler | DIRECTOR | -36.50K | $3.00 | -$109.50K | SELL | -0.74% | 4.92M | May 11 | View |
| May 07, 2010 | Michael Schmertzler | DIRECTOR | -33.45K | $3.03 | -$101.34K | SELL | -0.67% | 4.95M | May 06 | View |
| May 07, 2010 | Michael Schmertzler | DIRECTOR | -402.10K | $3.04 | -$1.22M | SELL | -7.46% | 4.99M | May 05 | View |
| Apr 28, 2010 | James H Sabry | — | 0.00 | $2.19 | -$19.78K | SELL-OPTIONS | 0.00% | 0.00 | Apr 26 | View |
| Apr 01, 2010 | James H Sabry | — | 0.00 | $2.22 | -$20.32K | SELL-OPTIONS | 0.00% | 0.00 | Mar 31 | View |
| Feb 22, 2010 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.17 | -$970.00 | SELL-OPTIONS | 0.00% | 30.92K | Feb 18 | View |
| Feb 12, 2010 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.08 | -$880.00 | SELL-OPTIONS | 0.00% | 30.92K | Feb 11 | View |
| Jan 21, 2010 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.27 | -$1.07K | SELL-OPTIONS | 0.00% | 30.92K | Jan 19 | View |
| Jan 07, 2010 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.15 | -$955.00 | SELL-OPTIONS | 0.00% | 30.92K | Jan 05 | View |
| Dec 17, 2009 | James H Sabry | DIRECTOR | -500.00 | $3.09 | -$1.54K | SELL | -100.00% | 0.00 | Dec 16 | View |
| Dec 17, 2009 | James H Sabry | DIRECTOR | 500.00 | $1.91 | -$121.89K | SELL-OPTIONS | ∞ | 500.00 | Dec 15 - Dec 16 | View |
| Dec 17, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.13 | -$925.00 | SELL-OPTIONS | 0.00% | 30.92K | Dec 15 | View |
| Dec 04, 2009 | James H Sabry | DIRECTOR | 0.00 | $1.86 | -$124.80K | SELL-OPTIONS | 0.00% | 0.00 | Dec 02 | View |
| Dec 03, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.16 | -$960.00 | SELL-OPTIONS | 0.00% | 30.92K | Dec 01 | View |
| Nov 25, 2009 | Robert I Blum | PRESIDENT & CEO | -4.04K | $2.33 | -$1.14K | SELL | -11.57% | 30.92K | Nov 20 - Nov 24 | View |
| Nov 18, 2009 | James H Sabry | DIRECTOR | 0.00 | $2.32 | -$109.54K | SELL-OPTIONS | 0.00% | 0.00 | Nov 17 | View |
| Nov 17, 2009 | James H Sabry | DIRECTOR | -32.26K | $2.18 | -$347.40K | SELL | -100.00% | 0.00 | Sep 17 - Nov 16 | View |
| Nov 12, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.22 | -$1.02K | SELL-OPTIONS | 0.00% | 34.96K | Nov 10 | View |
| Oct 23, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.98 | -$1.78K | SELL-OPTIONS | 0.00% | 34.96K | Oct 22 | View |
| Oct 09, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.02 | -$1.82K | SELL-OPTIONS | 0.00% | 34.96K | Oct 08 | View |
| Oct 02, 2009 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -7.50K | $5.20 | -$38.98K | SELL | -15.15% | 42.00K | Oct 01 | View |
| Sep 29, 2009 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -2.50K | $5.50 | -$13.75K | SELL | -4.81% | 49.50K | Sep 28 | View |
| Sep 25, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.91 | -$1.71K | SELL-OPTIONS | 0.00% | 34.96K | Sep 24 | View |
| Sep 22, 2009 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -7.50K | $4.83 | -$36.23K | SELL | -12.61% | 52.00K | Sep 21 | View |
| Sep 11, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.21 | -$1.00K | SELL-OPTIONS | 0.00% | 34.96K | Sep 10 | View |
| Aug 21, 2009 | James H Sabry | DIRECTOR | 0.00 | $1.71 | -$110.59K | SELL-OPTIONS | 0.00% | 49.55K | Aug 19 - Aug 20 | View |
| Aug 19, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.00 | -$805.00 | SELL-OPTIONS | 0.00% | 34.96K | Aug 18 | View |
| Aug 19, 2009 | James H Sabry | DIRECTOR | 0.00 | $1.67 | -$29.26K | SELL-OPTIONS | 0.00% | 49.55K | Aug 17 | View |
| Aug 06, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.10 | -$1.80K | SELL-OPTIONS | 0.00% | 34.96K | Aug 04 | View |
| Jul 24, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.02 | -$1.63K | SELL-OPTIONS | 0.00% | 34.96K | Jul 22 | View |
| Jul 10, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.96 | -$1.52K | SELL-OPTIONS | 0.00% | 34.96K | Jul 08 | View |
| Jun 30, 2009 | James H Sabry | EXECUTIVE CHAIRMAN | -40.00K | $2.85 | -$113.93K | SELL | -44.67% | 49.55K | Jun 26 - Jun 29 | View |
| Jun 23, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.97 | -$1.54K | SELL-OPTIONS | 0.00% | 34.96K | Jun 22 | View |
| Jun 10, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.08 | -$1.77K | SELL-OPTIONS | 0.00% | 34.96K | Jun 08 | View |
| Jun 08, 2009 | James H Sabry | EXECUTIVE CHAIRMAN | -60.00K | $2.86 | -$171.70K | SELL | -40.12% | 89.55K | Jun 04 - Jun 05 | View |
| May 26, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$800.00 | SELL-OPTIONS | 0.00% | 34.96K | May 22 | View |
| May 22, 2009 | Michael Schmertzler | DIRECTOR | 1.52M | $1.97 | $3.00M | BUY | 39.39% | 5.39M | May 21 | View |
| May 19, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$800.00 | SELL-OPTIONS | 0.00% | 34.96K | May 18 | View |
| May 08, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$800.00 | SELL-OPTIONS | 0.00% | 34.96K | May 06 | View |
| May 05, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$3.74K | SELL-OPTIONS | 0.00% | 34.96K | May 01 | View |
| Apr 28, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$259.20 | SELL-OPTIONS | 0.00% | 34.96K | Apr 24 | View |
| Apr 23, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$22.40K | SELL-OPTIONS | 0.00% | 34.96K | Apr 21 - Apr 22 | View |
| Apr 01, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$1.60K | SELL-OPTIONS | 0.00% | 34.96K | Mar 30 | View |
| Mar 27, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.60 | -$16.00K | SELL-OPTIONS | 0.00% | 34.96K | Mar 26 | View |
| Mar 18, 2009 | Robert I Blum | PRESIDENT & CEO | 0.00 | $1.29 | -$7.81K | SELL-OPTIONS | 0.00% | 34.96K | Mar 16 - Mar 17 | View |
| Mar 03, 2009 | David J. Morgans Jr. Ph.D. | EVP-PRECLINICAL R&D | -5.00K | $1.54 | -$7.72K | SELL | -7.75% | 59.50K | Mar 02 | View |
| Feb 04, 2009 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -5.00K | $2.15 | -$10.75K | SELL | -7.19% | 64.50K | Feb 02 | View |
| Jan 05, 2009 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -5.00K | $2.84 | -$14.19K | SELL | -6.71% | 69.50K | Jan 02 | View |
| Dec 02, 2008 | David J. Morgans Jr., Ph.D. | EVP-PRECLINICAL R&D | -5.00K | $2.15 | -$10.76K | SELL | -6.29% | 74.50K | Dec 01 | View |
| Nov 04, 2008 | David J. Morgans Jr. Ph.D. | EVP-PRECLINICAL R&D | -5.00K | $2.92 | -$14.60K | SELL | -5.92% | 79.50K | Nov 03 | View |
| Sep 30, 2008 | James H Sabry | EXECUTIVE CHAIRMAN | -20.00K | $4.88 | -$97.51K | SELL | -11.80% | 149.55K | Sep 26 | View |
| Sep 26, 2008 | James H Sabry | EXECUTIVE CHAIRMAN | -20.00K | $4.84 | -$96.80K | SELL | -10.55% | 169.55K | Sep 24 | View |
| Sep 17, 2008 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.10 | -$22.18K | SELL-OPTIONS | 0.00% | 34.96K | Sep 15 | View |
| Sep 03, 2008 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.24 | -$39.57K | SELL-OPTIONS | 0.00% | 34.96K | Aug 29 | View |
| Aug 18, 2008 | Robert I Blum | PRESIDENT & CEO | -1.41K | $3.10 | -$21.83K | SELL | -3.88% | 34.96K | Aug 15 | View |
| Aug 04, 2008 | Robert I Blum | PRESIDENT & CEO | -7.35K | $3.50 | -$76.65K | SELL | -16.81% | 36.37K | Jul 31 | View |
| Apr 25, 2008 | James A Spudich | DIRECTOR | -2.00K | $3.32 | -$6.63K | SELL | -1.10% | 180.60K | Apr 25 | View |
| Mar 21, 2008 | James A Spudich | DIRECTOR | -2.00K | $3.38 | -$6.76K | SELL | -1.08% | 182.60K | Mar 20 | View |
| Feb 29, 2008 | James A Spudich | DIRECTOR | -2.00K | $3.50 | -$7.00K | SELL | -1.07% | 184.60K | Feb 27 | View |
| Jan 10, 2008 | James A Spudich | DIRECTOR | -3.00K | $4.52 | -$13.55K | SELL | -1.58% | 186.60K | Jan 08 | View |
| Dec 14, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.69 | -$22.72K | SELL-OPTIONS | 0.00% | 43.72K | Dec 14 | View |
| Dec 11, 2007 | James A Spudich | DIRECTOR | -3.00K | $5.63 | -$16.88K | SELL | -1.56% | 189.60K | Dec 10 | View |
| Dec 03, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.10 | -$26.60K | SELL-OPTIONS | 0.00% | 192.55K | Dec 03 | View |
| Nov 30, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.60 | -$21.71K | SELL-OPTIONS | 0.00% | 43.72K | Nov 30 | View |
| Nov 16, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.50 | -$21.03K | SELL-OPTIONS | 0.00% | 43.72K | Nov 15 | View |
| Nov 02, 2007 | James A Spudich | DIRECTOR | -3.00K | $5.17 | -$15.52K | SELL | -1.53% | 192.60K | Nov 02 | View |
| Nov 01, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.10 | -$26.60K | SELL-OPTIONS | 0.00% | 192.55K | Nov 01 | View |
| Nov 01, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.50 | -$22.28K | SELL-OPTIONS | 0.00% | 43.72K | Oct 31 | View |
| Oct 17, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $4.02 | -$33.34K | SELL-OPTIONS | 0.00% | 51.22K | Oct 15 | View |
| Oct 03, 2007 | James A Spudich | DIRECTOR | -3.00K | $5.41 | -$16.23K | SELL | -1.51% | 195.60K | Oct 03 | View |
| Oct 02, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.11 | -$26.79K | SELL-OPTIONS | 0.00% | 198.15K | Oct 01 | View |
| Oct 02, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.54 | -$30.51K | SELL-OPTIONS | 0.00% | 51.22K | Sep 28 | View |
| Oct 01, 2007 | David J. Morgans Jr., Ph.D. | SVP-PRECLINICAL R&D | -5.00K | $5.09 | -$25.45K | SELL | -5.59% | 84.50K | Sep 28 | View |
| Sep 14, 2007 | David J. Morgans Jr., Ph.D. | SVP-PRECLINICAL R&D | 27.00K | $2.98 | $14.65K | SELL-OPTIONS | 43.20% | 89.50K | Sep 14 | View |
| Sep 06, 2007 | James A Spudich | DIRECTOR | -3.00K | $4.95 | -$14.86K | SELL | -1.49% | 198.60K | Sep 05 | View |
| Aug 31, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $3.54 | -$20.60K | SELL-OPTIONS | 0.00% | 51.22K | Aug 30 | View |
| Aug 20, 2007 | STEPHEN DOW | DIRECTOR | 20.00K | $5.07 | $101.42K | BUY | 0.61% | 3.31M | Aug 17 | View |
| Aug 16, 2007 | Robert I Blum | PRESIDENT & CEO | 0.00 | $2.81 | -$28.98K | SELL-OPTIONS | 0.00% | 51.22K | Aug 15 | View |
| Aug 02, 2007 | James A Spudich | DIRECTOR | -3.00K | $5.23 | -$15.69K | SELL | -1.47% | 201.60K | Aug 02 | View |
| Aug 02, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.10 | -$26.60K | SELL-OPTIONS | 0.00% | 198.15K | Aug 01 | View |
| Jul 31, 2007 | Robert I Blum | PRESIDENT & CEO | -6.13K | $2.79 | -$31.82K | SELL | -10.68% | 51.22K | Jul 31 | View |
| Jul 18, 2007 | Robert I Blum | PRESIDENT & CEO | -6.13K | $3.03 | -$33.90K | SELL | -9.65% | 57.35K | Jul 16 | View |
| Jul 03, 2007 | James A Spudich | DIRECTOR | -3.00K | $5.69 | -$17.06K | SELL | -1.45% | 204.60K | Jul 03 | View |
| Jul 03, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.45 | -$31.50K | SELL-OPTIONS | 0.00% | 198.15K | Jul 02 | View |
| Jul 02, 2007 | David J. Morgans Jr., Ph.D. | SVP-PRECLINICAL R&D | -5.00K | $6.00 | -$30.00K | SELL | -7.41% | 62.50K | Jun 29 | View |
| Jul 02, 2007 | Robert I Blum | PRESIDENT & CEO | -5.78K | $5.86 | -$33.87K | SELL | -8.34% | 63.48K | Jun 29 | View |
| Jun 19, 2007 | David J. Morgans Jr. Ph.D. | SVP-PRECLINICAL R&D | 22.50K | $3.83 | $700.00 | SELL-OPTIONS | 50.00% | 67.50K | Jun 15 | View |
| Jun 15, 2007 | Robert I Blum | PRESIDENT & CEO | -4.95K | $6.46 | -$31.98K | SELL | -6.67% | 69.25K | Jun 15 | View |
| Jun 12, 2007 | James H Sabry | EXECUTIVE CHAIRMAN | 0.00 | $3.57 | -$39.56K | SELL-OPTIONS | 0.00% | 198.15K | Jun 11 | View |
| Jun 06, 2007 | James A Spudich | DIRECTOR | -3.00K | $6.51 | -$19.54K | SELL | -1.42% | 207.60K | Jun 04 | View |
| May 31, 2007 | Robert I Blum | PRESIDENT & CEO | -3.30K | $6.50 | -$21.45K | SELL | -4.26% | 74.20K | May 29 | View |
| May 11, 2007 | James A Spudich | DIRECTOR | -3.00K | $6.67 | -$20.00K | SELL | -1.40% | 210.60K | May 11 | View |
| May 11, 2007 | Jay K Trautman | VP, DISCOVERY RESEARCH | -1.50K | $7.01 | -$10.52K | SELL | -7.73% | 17.90K | May 10 | View |
| Apr 11, 2007 | Jay K Trautman | VP, DISCOVERY RESEARCH | -1.50K | $7.05 | -$10.58K | SELL | -7.51% | 18.47K | Apr 10 | View |
| Mar 12, 2007 | Jay K Trautman | VP, RESEARCH | -1.50K | $7.12 | -$10.68K | SELL | -6.99% | 19.97K | Mar 09 | View |
| Feb 12, 2007 | Jay K Trautman | VP, RESEARCH | -1.50K | $8.00 | -$12.00K | SELL | -6.53% | 21.47K | Feb 09 | View |
| Feb 02, 2007 | James H Sabry | CEO | 0.00 | $4.55 | -$46.86K | SELL-OPTIONS | 0.00% | 199.50K | Feb 01 | View |
| Jan 17, 2007 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.75 | -$35.55K | SELL-OPTIONS | 0.00% | 45.00K | Jan 16 | View |
| Jan 12, 2007 | James A Spudich | DIRECTOR | -2.20K | $8.31 | -$18.28K | SELL | -1.02% | 213.60K | Jan 11 | View |
| Jan 12, 2007 | Jay K Trautman | VP, RESEARCH | -1.00K | $8.30 | -$8.30K | SELL | -4.17% | 22.97K | Jan 11 | View |
| Jan 05, 2007 | James H Sabry | CEO | 0.00 | $4.95 | -$52.51K | SELL-OPTIONS | 0.00% | 199.50K | Jan 03 | View |
| Dec 21, 2006 | James A Spudich | DIRECTOR | -2.20K | $6.83 | -$15.02K | SELL | -1.01% | 215.80K | Dec 21 | View |
| Dec 19, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.76 | -$31.80K | SELL-OPTIONS | 0.00% | 77.50K | Dec 15 | View |
| Dec 18, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.08 | -$28.75K | SELL-OPTIONS | 0.00% | 45.00K | Dec 15 | View |
| Dec 12, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.30 | -$7.30K | SELL | -4.00% | 23.97K | Dec 11 | View |
| Dec 04, 2006 | James H Sabry | CEO | 0.00 | $4.16 | -$44.43K | SELL-OPTIONS | 0.00% | 199.50K | Dec 01 | View |
| Dec 01, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.94 | -$33.57K | SELL-OPTIONS | 0.00% | 77.50K | Nov 30 | View |
| Nov 22, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.73 | -$17.00K | SELL | -1.00% | 218.00K | Nov 21 | View |
| Nov 16, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.50 | -$33.00K | SELL-OPTIONS | 0.00% | 45.00K | Nov 15 | View |
| Nov 16, 2006 | Robert I Blum | PRESIDENT | 0.00 | $4.10 | -$35.19K | SELL-OPTIONS | 0.00% | 77.50K | Nov 15 | View |
| Nov 15, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.29 | -$7.29K | SELL | -3.85% | 24.97K | Nov 10 | View |
| Nov 02, 2006 | James H Sabry | CEO | 0.00 | $3.94 | -$47.04K | SELL-OPTIONS | 0.00% | 199.50K | Nov 01 | View |
| Oct 31, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.80 | -$32.17K | SELL-OPTIONS | 0.00% | 77.50K | Oct 30 | View |
| Oct 25, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.01 | -$15.43K | SELL | -0.99% | 220.20K | Oct 24 | View |
| Oct 20, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.00 | -$7.00K | SELL | -3.84% | 25.05K | Oct 19 | View |
| Oct 18, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.66 | -$30.85K | SELL-OPTIONS | 0.00% | 77.50K | Oct 16 | View |
| Oct 16, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $3.94 | -$27.35K | SELL-OPTIONS | 0.00% | 45.00K | Oct 13 | View |
| Oct 04, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.51 | -$40.98K | SELL-OPTIONS | 0.00% | 210.00K | Oct 02 | View |
| Oct 03, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.48 | -$28.98K | SELL-OPTIONS | 0.00% | 77.50K | Oct 02 | View |
| Oct 03, 2006 | James A Spudich | DIRECTOR | -2.20K | $6.48 | -$14.26K | SELL | -0.98% | 222.40K | Sep 29 | View |
| Sep 19, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.67 | -$30.91K | SELL-OPTIONS | 0.00% | 77.50K | Sep 15 | View |
| Sep 18, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.11 | -$29.10K | SELL-OPTIONS | 0.00% | 45.00K | Sep 15 | View |
| Sep 14, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.00 | -$7.00K | SELL | -3.70% | 26.05K | Sep 12 | View |
| Sep 05, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.67 | -$43.25K | SELL-OPTIONS | 0.00% | 210.00K | Sep 01 | View |
| Sep 01, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.51 | -$29.30K | SELL-OPTIONS | 0.00% | 77.50K | Aug 30 | View |
| Aug 28, 2006 | James A Spudich | DIRECTOR | -2.20K | $6.08 | -$13.37K | SELL | -0.97% | 224.60K | Aug 25 | View |
| Aug 18, 2006 | David J. Morgans, Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $3.60 | -$24.00K | SELL-OPTIONS | 0.00% | 45.00K | Aug 18 | View |
| Aug 17, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.01 | -$24.30K | SELL-OPTIONS | 0.00% | 77.50K | Aug 15 | View |
| Aug 02, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.22 | -$36.94K | SELL-OPTIONS | 0.00% | 210.00K | Aug 01 | View |
| Aug 02, 2006 | James A Spudich | DIRECTOR | -2.20K | $5.87 | -$12.91K | SELL | -0.96% | 226.80K | Jul 25 | View |
| Aug 02, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.10 | -$25.23K | SELL-OPTIONS | 0.00% | 77.50K | Jul 31 | View |
| Jul 26, 2006 | David J. Morgans Jr. Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $3.60 | -$16.75K | SELL-OPTIONS | 0.00% | 45.00K | Jul 26 | View |
| Jul 26, 2006 | David J. Morgans Jr. Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $3.60 | -$7.25K | SELL-OPTIONS | 0.00% | 45.00K | Jul 25 | View |
| Jul 19, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.04 | -$24.58K | SELL-OPTIONS | 0.00% | 77.50K | Jul 17 | View |
| Jul 05, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.56 | -$41.72K | SELL-OPTIONS | 0.00% | 210.00K | Jul 03 | View |
| Jul 05, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.60 | -$30.12K | SELL-OPTIONS | 0.00% | 77.50K | Jun 30 | View |
| Jul 03, 2006 | James A Spudich | DIRECTOR | -2.20K | $6.49 | -$14.28K | SELL | -0.95% | 229.00K | Jun 29 | View |
| Jun 19, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.75 | -$31.69K | SELL-OPTIONS | 0.00% | 77.50K | Jun 15 | View |
| Jun 16, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 25.00K | $3.81 | -$14.15K | SELL-OPTIONS | 125.00% | 45.00K | Jun 15 | View |
| Jun 13, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.03 | -$7.03K | SELL | -3.56% | 27.05K | Jun 09 | View |
| Jun 02, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.74 | -$44.19K | SELL-OPTIONS | 0.00% | 210.00K | Jun 01 | View |
| Jun 01, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.82 | -$32.27K | SELL-OPTIONS | 0.00% | 77.50K | May 30 | View |
| May 24, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.28 | -$16.02K | SELL | -0.94% | 231.20K | May 22 | View |
| May 17, 2006 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.12 | -$29.15K | SELL-OPTIONS | 0.00% | 20.00K | May 15 | View |
| May 17, 2006 | Robert I Blum | PRESIDENT | 0.00 | $3.79 | -$31.82K | SELL-OPTIONS | 0.00% | 77.50K | May 15 | View |
| May 12, 2006 | Jay K Trautman | VP, RESEARCH | -1.00K | $7.87 | -$7.87K | SELL | -3.44% | 28.05K | May 10 | View |
| May 01, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.88 | -$46.22K | SELL-OPTIONS | 0.00% | 210.00K | May 01 | View |
| May 01, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.84 | -$32.12K | SELL-OPTIONS | 0.00% | 77.50K | May 01 | View |
| Apr 17, 2006 | Jay K Trautman | VP, DISC BIOLOGY & TECHNOLOGY | -1.00K | $7.34 | -$7.34K | SELL | -3.43% | 28.16K | Apr 17 | View |
| Apr 17, 2006 | David J. Morgans Jr. Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.17 | -$31.70K | SELL-OPTIONS | 0.00% | 20.00K | Apr 17 | View |
| Apr 17, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.96 | -$32.75K | SELL-OPTIONS | 0.00% | 77.50K | Apr 17 | View |
| Apr 04, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.60 | -$16.73K | SELL | -0.93% | 233.40K | Apr 04 | View |
| Apr 04, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $4.11 | -$1.25K | SELL-OPTIONS | 0.00% | 210.00K | Apr 03 | View |
| Apr 04, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $4.08 | -$47.70K | SELL-OPTIONS | 0.00% | 0.00 | Apr 03 | View |
| Mar 31, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.82 | -$30.38K | SELL-OPTIONS | 0.00% | 77.50K | Mar 30 | View |
| Mar 17, 2006 | Jay K Trautman | VP, DISC BIOLOGY & TECHNOLOGY | -1.00K | $7.01 | -$7.01K | SELL | -3.32% | 29.16K | Mar 15 | View |
| Mar 16, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.79 | -$28.13K | SELL-OPTIONS | 0.00% | 77.50K | Mar 15 | View |
| Mar 16, 2006 | David J. Morgans Jr. Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.00 | -$30.05K | SELL-OPTIONS | 0.00% | 20.00K | Mar 15 | View |
| Mar 03, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.09 | -$15.61K | SELL | -0.93% | 235.60K | Mar 02 | View |
| Mar 02, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.86 | -$45.99K | SELL-OPTIONS | 0.00% | 210.00K | Mar 01 | View |
| Mar 01, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.84 | -$24.45K | SELL-OPTIONS | 0.00% | 77.50K | Feb 28 | View |
| Feb 17, 2006 | STEPHEN DOW | DIRECTOR | 7.00K | $7.44 | $52.11K | BUY | 0.21% | 3.29M | Feb 15 - Feb 16 | View |
| Feb 16, 2006 | David J. Morgans Jr. Ph.D. | SVP-DRUG DISCOVERY AND DEV | 0.00 | $4.09 | -$30.92K | SELL-OPTIONS | 0.00% | 20.00K | Feb 15 | View |
| Feb 16, 2006 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $3.86 | -$16.40K | SELL-OPTIONS | 0.00% | 77.50K | Feb 15 | View |
| Feb 15, 2006 | STEPHEN DOW | DIRECTOR | 33.00K | $7.22 | $238.24K | BUY | 1.02% | 3.28M | Feb 13 - Feb 14 | View |
| Feb 09, 2006 | James H Sabry | PRESIDENT AND CEO | 0.00 | $3.97 | -$47.46K | SELL-OPTIONS | 0.00% | 210.00K | Feb 08 | View |
| Feb 07, 2006 | James A Spudich | DIRECTOR | -2.20K | $7.71 | -$16.97K | SELL | -0.92% | 237.80K | Feb 03 | View |
| Nov 16, 2005 | STEPHEN DOW | DIRECTOR | 3.19M | $8.53 | $213.19K | BUY | ∞ | 3.16M | Apr 29 - Nov 15 | View |
| Nov 15, 2005 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $4.75 | -$41.24K | SELL-OPTIONS | 0.00% | 77.50K | Nov 14 | View |
| Nov 15, 2005 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $4.77 | -$137.18K | SELL-OPTIONS | 0.00% | 65.00K | Nov 11 - Nov 14 | View |
| Nov 09, 2005 | James H Sabry | PRESIDENT AND CEO | -2.00K | $8.50 | -$17.00K | SELL | -0.94% | 210.00K | Nov 08 | View |
| Nov 09, 2005 | Robert I Blum | EVP, CORP. DEVELOPMENT & CBO | 0.00 | $4.89 | -$73.87K | SELL-OPTIONS | 0.00% | 77.50K | Nov 07 - Nov 08 | View |
| Nov 08, 2005 | James H Sabry | PRESIDENT AND CEO | -6.00K | $8.70 | -$52.20K | SELL | -2.75% | 212.00K | Nov 07 | View |
| Nov 04, 2005 | Jay K Trautman | VP, DISC BIOLOGY & TECHNOLOGY | -18.10K | $7.69 | -$139.10K | SELL | -37.51% | 30.16K | Nov 03 | View |
| Nov 04, 2005 | Jay K Trautman | VP, DISC BIOLOGY & TECHNOLOGY | -13.90K | $7.33 | -$101.88K | SELL | -22.36% | 48.26K | Nov 03 | View |
| Nov 04, 2005 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | -22.50K | $7.82 | -$176.00K | SELL | -100.00% | 0.00 | Nov 03 | View |
| Nov 04, 2005 | David J. Morgans Jr., Ph.D. | SVP-DRUG DISCOVERY AND DEV | -12.50K | $7.46 | -$93.19K | SELL | -35.71% | 22.50K | Nov 02 | View |
| Feb 28, 2005 | Robert Blum | EVP, CORP. DEVELOPMENT & CBO | -5.00K | $9.66 | -$48.32K | SELL | -5.80% | 81.25K | Feb 25 | View |
| Feb 28, 2005 | Robert Blum | EVP, CORP. DEVELOPMENT & CBO | -5.00K | $9.25 | -$46.25K | SELL | -5.48% | 86.25K | Feb 24 | View |
| Feb 15, 2005 | Robert Blum | EVP, CORP. DEVELOPMENT & CBO | -10.00K | $9.50 | -$95.00K | SELL | -9.88% | 91.25K | Feb 14 | View |
| Nov 29, 2004 | GRANT HEIDRICH III | DIRECTOR | -100.00K | $8.61 | -$861.17K | SELL | -44.88% | 122.80K | Nov 24 - Nov 29 | View |
| Oct 29, 2004 | STEPHEN DOW | DIRECTOR | 60.00K | $8.49 | $509.56K | BUY | 1.90% | 3.22M | Oct 27 - Oct 28 | View |